Hims & Hers Health shares technical analysis: Upward price move faces $27.64 resistance

Traders Union
All News
Stocks
Hims & Hers Health gains 1.84% today

Highlights

HIMS/USD trades below key short-term and long-term moving averages, showing continued downward pressure across primary timeframes.
Momentum signals such as MACD and ADX support a bearish outlook, with oscillators mostly neutral and no reversal signals in sight.
Forecast sees a 76% chance of a move lower, with price expected to fluctuate between $23.49 and $27.91 over the next sessions.

Sell momentum prevails amid resistance at Ichimoku Kijun level

On the technical front, HIMS has failed to reclaim the MA-20 and MA-50 on the hourly chart, while also trading below the MA-200 on the daily timeframe. Immediate upside resistance is defined by the Ichimoku Kijun level at $27.64. Momentum indicators show both MACD and ADX signaling sell conditions, while RSI, Stoch RSI, and CCI remain neutral. Bull/Bear Power at –0.37 highlights intraday seller dominance, and the Awesome Oscillator is neutral, not confirming further downside at present. There are no signals from oscillators indicating an imminent reversal.

Downside risk dominates with range-bound outlook and breakout triggers

Looking ahead, HIMS is expected to trade within a volatility band between $23.49 and $27.91 over the next few sessions. The probability of an upward breakout is 24%, while a decline remains more likely at 76%. The base case anticipates sideways movement in this range, with bullish continuation requiring a price close above $27.64, and a bearish scenario unfolding if the stock drops below $23.49.

Viktoras Karapetjanc, expert at Traders Union, sees continued downward pressure on HIMS despite a modest session gain. The technical backdrop is still bearish, with the price unable to reclaim key moving averages and sell signals dominating momentum indicators. He believes the base case is sideways movement within the $23.49–$27.91 range, with a higher probability of further downside. The analyst is cautiously optimistic, noting that bullish momentum could emerge on a close above $27.64. "I am watching for a breakout above resistance, but as long as HIMS remains below the $27.64 level, risk of further declines stays elevated."

Earlier, analysts noted that Hims & Hers Health faced persistent technical and legal pressures that contributed to its bearish outlook. The current analysis reinforces this view, highlighting a prevailing downside risk within the established $23.49–$27.91 volatility band and pointing to a critical inflection if the lower boundary is breached.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.